je.st
news
How Gilead Sciences Is Gouging Hepatitis C Patients, $1,000 a Pill
2015-06-21 20:06:31| Biotech - Topix.net
A new wave of hepatitis C drugs is all the rage. But while these new pills boast cure rates of 90 percent in less time than their predecessors, their prices are causing rage.
Tags: sciences
patients
pill
hepatitis
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||